Anticancer or carcinogenic? The role of estrogen receptor β in breast cancer progression

K Shen, H Yu, B Xie, Q Meng, C Dong, K Shen… - Pharmacology & …, 2023 - Elsevier
Estrogen receptor β (ERβ) is closely related to breast cancer (BC) progression. Traditional
concepts regard ERβ as a tumor suppressor. As studies show the carcinogenic effect of …

Autophagy in human health and disease: novel therapeutic opportunities

F Giampieri, S Afrin, TY Forbes-Hernandez… - Antioxidants & redox …, 2019 - liebertpub.com
Significance: In eukaryotes, autophagy represents a highly evolutionary conserved process,
through which macromolecules and cytoplasmic material are degraded into lysosomes and …

Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors

H Dalal, M Dahlgren, S Gladchuk, C Brueffer… - Scientific reports, 2022 - nature.com
Estrogen receptor alpha (ERα, encoded by ESR1) is a well-characterized transcription factor
expressed in more than 75% of breast tumors and is the key biomarker to direct endocrine …

Tamoxifen action in ER-negative breast cancer

S Manna, MK Holz - Signal transduction insights, 2016 - journals.sagepub.com
Breast cancer is a highly heterogeneous disease. Tamoxifen is a selective estrogen receptor
(ER) modulator and is mainly indicated for the treatment of breast cancer in postmenopausal …

SIRT3 silencing sensitizes breast cancer cells to cytotoxic treatments through an increment in ROS production

M Torrens‐Mas, DG Pons… - Journal of cellular …, 2017 - Wiley Online Library
ABSTRACT SIRT3, the major deacetylase in mitochondria, plays a crucial role modulating
ROS production and scavenging by regulating key proteins implicated in mitochondrial …

The role of estrogen receptor beta in breast cancer

Y Zhou, X Liu - Biomarker research, 2020 - Springer
Breast cancer, a malignant tumor originating from mammary epithelial tissue, is the most
common cancer among women worldwide. Challenges facing the diagnosis and treatment …

Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes

Z Xu, B Huang, J Liu, X Wu, N Luo, X Wang, X Zheng… - Toxicology, 2018 - Elsevier
Breast cancer is the most diagnosed diseases and the second-leading cause of death in
females, among which the estrogen receptor positive (ER+) patients are more common of all …

The phytoestrogen genistein affects inflammatory-related genes expression depending on the ERα/ERβ ratio in breast cancer cells

DG Pons, J Vilanova-Llompart… - … journal of food …, 2019 - Taylor & Francis
Breast cancer is the most common malignancy in women of developed countries. The aim of
this study was to investigate the effects of the phytoestrogen genistein on the inflammatory …

Estradiol signaling mediates gender difference in visceral adiposity via autophagy

Z Tao, LD Zheng, C Smith, J Luo, A Robinson… - Cell death & …, 2018 - nature.com
Excessive adiposity (particularly visceral fat mass) increases the risks of developing
metabolic syndrome. Women have lower deposit of visceral fat than men, and this pattern …

Estrogen-and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer

C Berkel, E Cacan - Life Sciences, 2021 - Elsevier
Cisplatin is a platinum-based chemotherapeutic drug used in the standard treatment of
various solid cancers including testicular, bladder, head and neck, cervical and ovarian …